State Street Corp Boosts Holdings in InfuSystem Holdings, Inc. (NYSE:INFU)

State Street Corp raised its position in InfuSystem Holdings, Inc. (NYSE:INFU) by 1.1% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 267,012 shares of the company’s stock after buying an additional 3,019 shares during the quarter. State Street Corp’s holdings in InfuSystem were worth $1,789,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the company. First Eagle Investment Management LLC increased its stake in shares of InfuSystem by 10.0% during the second quarter. First Eagle Investment Management LLC now owns 666,048 shares of the company’s stock worth $4,549,000 after acquiring an additional 60,813 shares during the period. Greenwood Capital Associates LLC boosted its holdings in InfuSystem by 14.0% in the 3rd quarter. Greenwood Capital Associates LLC now owns 119,062 shares of the company’s stock valued at $798,000 after purchasing an additional 14,587 shares in the last quarter. Bank of New York Mellon Corp increased its position in InfuSystem by 6.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 93,899 shares of the company’s stock worth $641,000 after purchasing an additional 5,391 shares during the period. GSA Capital Partners LLP raised its stake in shares of InfuSystem by 23.9% during the 3rd quarter. GSA Capital Partners LLP now owns 65,680 shares of the company’s stock worth $440,000 after buying an additional 12,657 shares in the last quarter. Finally, Perritt Capital Management Inc raised its stake in shares of InfuSystem by 169.4% during the 2nd quarter. Perritt Capital Management Inc now owns 38,500 shares of the company’s stock worth $263,000 after buying an additional 24,207 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.

InfuSystem Trading Up 5.6 %

Shares of INFU opened at $8.45 on Thursday. The business’s 50-day moving average is $8.23. InfuSystem Holdings, Inc. has a twelve month low of $5.74 and a twelve month high of $10.58. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $179.68 million, a price-to-earnings ratio of 140.86 and a beta of 1.53.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on INFU shares. StockNews.com raised InfuSystem from a “buy” rating to a “strong-buy” rating in a report on Friday, November 8th. B. Riley initiated coverage on shares of InfuSystem in a research report on Thursday, September 26th. They set a “buy” rating and a $13.00 target price on the stock.

Insider Buying and Selling

In related news, CEO Richard Dilorio sold 5,398 shares of the business’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $8.87, for a total value of $47,880.26. Following the sale, the chief executive officer now directly owns 416,659 shares in the company, valued at $3,695,765.33. The trade was a 1.28 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 10.20% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.